Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant T Cell Receptor anticorps

Cet anticorps Lapin Chimeric détecte spécifiquement dans FACS, IP, IF et BR. Il présente une réactivité envers Humain.
N° du produit ABIN7543145

Aperçu rapide pour Recombinant T Cell Receptor anticorps (ABIN7543145)

Antigène

T Cell Receptor

Type d'anticorp

Recombinant Antibody

Reactivité

  • 7
  • 4
Humain

Hôte

  • 4
  • 3
  • 2
  • 2
Lapin

Clonalité

  • 9
  • 2
Chimeric

Conjugué

  • 10
  • 1
Inconjugué

Application

  • 11
  • 7
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Flow Cytometry (FACS), Immunoprecipitation (IP), Immunofluorescence (IF), Blocking Reagent (BR)

Clone

BMA031
  • Fonction

    Anti-TCR [BMA031], Rabbit IgG, kappa

    Specificité

    This antibody reacts with surface receptors on all alpha-beta TCR bearing cells, but does not react with receptors on gamma-delta T cells. TCR-αβ is expressed by the majority of mature CD3+ T cells.

    Attributs du produit

    Original Species of Ab: Mouse

    Original Format of Ab: IgG2b

    Purification

    Protein A affinity purified

    Immunogène

    The original antibody was generated by immunizing mice with human perihperal blood T-lymphocytes.

    Isotype

    IgG kappa
  • Indications d'application

    This antibody is recomended for detection of viable human αβ+ TCR lymphocyte. It is highly effective in modulating immune reactions and is capable of activating human T lymphocytes in vito (PMID: 3092794). Double immunofluorescence staining was used to ascertain that this antibody does not cross react with γδ+ TCR cells. FACS analysis confirmed that BMA031 did not react with γδ+ TCR cells. BMA031 successfully precipitates TCR αβ/CDR complex (PMID: 1704361). BMA031 in conjugation with triple drug induction treatment in kidney-transplanted patients showed no side effects and reduction in graft rejections (PMID: 2978369). A clinical phase II trial administered 50 mg of murine anti-human alpha/beta-TCR mAb (BMA 031) intravenously on the day of, as well as 2 and 4 days after, cadaveric donor renal transplantation in combination with a CsA/prednisone regimen. After a minimum of 30 months follow-up, the actual allograft survival rate was 87 % in the BMA-treated group compared with 68 % in the control cohort (PMID: 8009591).Humanized version of this antibody BMA 031-EUCIV3 is found to have 2.5 times less affinity than its murine parent, however the ability to cause antibody dependent cell-mediated cytolysis was significantly enhanced (PMID: 1836485).

    Commentaires

    This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène

    T Cell Receptor

    Autre désignation

    TCR

    Sujet

    Human α/β T Cell Receptor (TCR)
Vous êtes ici:
Chat with us!